NodThera Competitors and Similar CompaniesClear all
Akero Therapeutics's competitors and similar companies include Inflazome.
 Akero Therapeutics Akero Therapeutics develops medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. |  Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | |
Founding Date | Founding Date 2017 | Founding Date 2016 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations San Francisco, US HQ Cambridge, US South San Francisco, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB |
Employees | Employees 1363% increase | Employees 156% decrease |
Funding | ||
Total funding raised | Total funding raised $ 135m | Total funding raised $ 17m |
For sources of this data, please see the company profile
View Company Profiles
Inflazome
HQ
Dublin 2, IE
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View company